WHO chief praises Guineans for help with Ebola vaccine

May 4, 2017

The head of the World Health Organization is praising Guineans for their role in helping to develop a vaccine against the deadly Ebola virus.

On a visit to the country where the world's deadliest Ebola outbreak emerged in 2013, Dr. Margaret Chan said Guineans had "fought back" by helping scientists.

There is no licensed treatment for Ebola, and the outbreak killed more than 11,300 people. Researchers began testing the vaccine as the outbreak was waning.

WHO, which has acknowledged shortcomings in its response to the Ebola outbreak in West Africa, led the study of the vaccine.

The vaccine was developed by the Canadian government and is now licensed to the U.S.-based Merck & Co.

Chan says the 's impact will be significant even if supplies initially are limited.

Explore further: Ebola vaccine shows 'promising' results: WHO

Related Stories

Ebola vaccine shows 'promising' results: WHO

July 31, 2015
Preliminary results of tests on an Ebola vaccine to be published later Friday in British science magazine The Lancet have shown "promising" results, World Health Organization Director-General Margaret Chan said.

Johnson & Johnson starts Ebola vaccine trial in Sierra Leone

October 9, 2015
Johnson & Johnson has begun clinical trials for an Ebola vaccine in Sierra Leone.

Russia says its Ebola vaccine 'effective' in initial tests

February 15, 2016
Russia's health minister said Monday that an Ebola vaccine developed by the country over the last 15 months had shown encouraging results and would undergo further testing in West Africa.

Global Vaccine promises $5 million to develop Ebola vaccine

January 20, 2016
The global vaccine alliance GAVI says it will donate $5 million toward developing the leading Ebola vaccine, hoping that it will be approved by a regulator by the end of 2017.

Ebola vaccine trial begins in Sierra Leone

April 14, 2015
Thousands of healthcare workers in areas of Sierra Leone that are grappling with Ebola will now begin receiving an experimental vaccine against the often deadly virus, officials said Tuesday.

WHO yet to take Canada's experimental Ebola vaccine

October 9, 2014
Doses of a prototype Ebola vaccine developed by Canada remain in the country even though they were offered to the World Health Organization nearly two months ago, the health minister said Thursday.

Recommended for you

Tibetan sheep highly susceptible to human plague, originates from marmots

August 16, 2018
In the Qinghai-Tibet plateau, one of the region's highest risk areas for human plague, Himalayan marmots are the primary carriers of the infectious bacterium Y. pestis. Y. pestis infection can be transmitted to humans and ...

Autoimmunity plays role in development of COPD, study finds

August 16, 2018
Autoimmunity plays a role in the development of chronic obstructive pulmonary disease (COPD), according to a study led by Georgia State University and Vanderbilt University Medical Center that analyzed human genome information ...

Reliable point-of-care blood test can help prevent toxoplasmosis

August 16, 2018
A recent study, performed in Chicago and Rabat, Morocco, found that a novel finger-prick test for infection with the parasite Toxoplasma gondii during pregnancy—and many other potential applications—is 100 percent sensitive ...

Scientists identify nearly 200 potential tuberculosis drug targets

August 16, 2018
Tuberculosis is one of the top 10 causes of death worldwide. Nearly 2 million people die every year from this infectious disease, and an estimated 2 billion people are chronically infected. The only vaccine, developed almost ...

First mouse model to mimic lung disease could speed discovery of more effective treatments

August 16, 2018
The biggest hurdle to finding effective therapies for idiopathic pulmonary fibrosis (IPF) – a life-threatening condition in which the lungs become scarred and breathing is increasingly difficult – has been the inability ...

Anticancer drug offers potential alternative to transplant for patients with liver failure

August 15, 2018
Patients suffering sudden liver failure could in the future benefit from a new treatment that could reduce the need for transplants, research published today shows.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.